DTP348, with the CAS number 1383370-92-0, is a chemical compound that has garnered attention in various fields, particularly in medicinal chemistry and drug development. While specific characteristics such as its molecular structure, physical properties, and biological activity may vary, compounds like DTP348 are often evaluated for their efficacy, safety, and mechanism of action. Typically, such substances may exhibit properties like solubility in organic solvents, stability under certain conditions, and specific reactivity with biological targets. In the context of drug development, DTP348 may be investigated for its potential therapeutic applications, including its pharmacokinetics and pharmacodynamics. Additionally, the compound's safety profile, including toxicity and side effects, would be critical in determining its suitability for clinical use. As research progresses, more detailed information regarding its characteristics, including synthesis methods and potential applications, may become available, contributing to a better understanding of its role in scientific and medical contexts.

DTP348

1383370-92-0: DTP348, with the CAS number 1383370-92-0, is a chemical compound that has garnered attention in various fields, particularly in medicinal chemistry and drug development. While specific characteristics such as its molecular structure, physical properties, and biological activity may vary, compounds like DTP348 are often evaluated for their efficacy, safety, and mechanism of action. Typically, such substances may exhibit properties like solubility in organic solvents, stability under certain conditions, and specific reactivity with biological targets. In the context of drug development, DTP348 may be investigated for its potential therapeutic applications, including its pharmacokinetics and pharmacodynamics. Additionally, the compound's safety profile, including toxicity and side effects, would be critical in determining its suitability for clinical use. As research progresses, more detailed information regarding its characteristics, including synthesis methods and potential applications, may become available, contributing to a better understanding of its role in scientific and medical contexts.

1-(2-Sulfamidoethyl)-2-methyl-5-nitroimidazole

DTP348: Oral carbonic anhydrase IX inhibitor & hypoxic cell radiosensitizer with sulfamide & 5-nitroimidazole components.

CAS 1383370-92-0

DTP348

1-(2-Sulfamidoethyl)-2-methyl-5-nitroimidazole

Ref: TR-S699350

DTP348

Ref: TM-T70813